Today: 20 March 2026
ELF Stock Today (Nov. 5, 2025): e.l.f. Beauty plunges after Q2 revenue miss; FY26 outlook lags Street as tariffs bite
5 November 2025
2 mins read

ELF Stock Today (Nov. 5, 2025): e.l.f. Beauty plunges after Q2 revenue miss; FY26 outlook lags Street as tariffs bite

At a glance (Nov. 5, 2025)

  • Q2 FY26 net sales: $343.9M, +14% YoY; gross margin: 69% (−165 bps); adj. EPS: $0.68. Business Wire
  • Guidance: FY26 net sales $1.55B–$1.57B; adj. EPS $2.80–$2.85 (below consensus). Business Wire+1
  • After-hours move: shares down ~19% on the outlook and tariff commentary; ~75% of products sourced from China; tariff hit seen >$50M annually. Reuters

What happened today

e.l.f. Beauty reported second‑quarter fiscal 2026 (quarter ended Sept. 30, 2025) results showing net sales of $343.9 million (+14% YoY), gross margin of 69% (down 165 bps primarily on higher tariff costs), and adjusted EPS of $0.68. Management highlighted this as the 27th consecutive quarter of net‑sales growth and cited a record launch of Rhode in Sephora North America. Business Wire

Why the stock sank after the bell

After the release, shares fell about 19% in extended trading as the company’s FY26 outlooknet sales $1.55–$1.57 billion; adjusted EPS $2.80–$2.85—landed below Wall Street estimates (roughly $1.65B and $3.58, respectively). Management commentary also underscored tariff headwinds, with ~75% of products made in China and tariff costs projected at >$50 million annually. Reuters

How results compared with expectations

Top line missed the Street’s Q2 revenue view (about $366.4M), but adjusted EPS beat (reported $0.68 vs. $0.57 expected). On a GAAP basis, net income was $3.0M (EPS $0.05) for the quarter. Reuters+1

The details investors care about

  • Margins & spending: The 165 bps gross‑margin compression to 69% was “primarily driven by higher tariff costs” (pricing/mix was a partial offset). Adjusted EBITDA was $66.2M (19% of sales). Business Wire
  • Adjusted profitability:Adjusted net income $40.7M; adjusted EPS $0.68 for Q2. Business Wire
  • Balance sheet (9/30):Cash $194.4M; long‑term debt $831.6M. Business Wire
  • Rhode update: Management called out a record‑breaking Sephora North America launch for Rhode, which is now part of the portfolio alongside e.l.f. Cosmetics, e.l.f. SKIN, Keys Soulcare, Well People, and Naturium. Business Wire

Guidance snapshot (FY26)

  • Net sales:$1.55B–$1.57B (+18%–20% vs. FY25).
  • Adjusted EPS:$2.80–$2.85.
  • Adjusted EBITDA:$302M–$306M; adj. effective tax rate:23%; FY diluted shares:~59M.
    These figures set the bar beneath consensus and, paired with tariff commentary, drove the after‑hours selloff. Business Wire+1

Key timing

Management scheduled a webcast at 4:30 p.m. ET today (Nov. 5) to discuss results and outlook; an archived replay will be posted on the investor site. Business Wire


Quick take

e.l.f. continues to grow revenue and win shelf space, but tariff‑driven cost pressure and a more cautious FY26 profit outlook overshadowed the quarter. The revenue miss and lower guide—even as adjusted EPS beat in Q2—signal a year where marketing and integration investments (and tariffs) could keep a lid on margin expansion. Traders focused on those forward‑looking pressures, not the streak of top‑line growth.


News roundup — Nov. 5, 2025

  • Reuters: Elf Beauty shares slump after annual sales forecast comes below estimates — details on the ~19% after‑hours drop, tariff exposure (~75% China) and >$50M tariff cost; consensus comparisons. Reuters
  • Business Wire (company release): e.l.f. Beauty Announces Second Quarter Fiscal 2026 Results — full Q2 line items, margin commentary, and FY26 guidance. Business Wire
  • Associated Press: Fiscal Q2 earnings snapshot — confirms GAAP EPS $0.05 and FY26 ranges. Seattle Post-Intelligencer

Bottom line

For today (Nov. 5, 2025), the story on ELF stock is straightforward: solid Q2 growth, but a softer‑than‑hoped FY26 profit outlook plus tariff overhang sent the stock sharply lower after hours. Keep an eye on any updated color from the evening call regarding price actions, tariff mitigation, and Rhode’s rollout, as these will be key to the holiday‑quarter setup. Business Wire

This article is for information only and is not investment advice.

Stock Market Today

  • Market Madness: Palantir Outpaces Procter & Gamble in Growth Prospects, Robinhood Beats UnitedHealth
    March 20, 2026, 5:50 PM EDT. In the 'Market Madness' stock showdown, Palantir edges out Procter & Gamble due to its strong growth driven by AI and productivity gains, despite Procter & Gamble's steady dividend and market resilience. Palantir's shares have surged 65% over the past year amid robust AI capital expenditure, indicating promising revenue growth ahead. Meanwhile, Robinhood is favored over UnitedHealth with anticipated earnings growth of 21% over several years, contrasting with regulatory uncertainties clouding UnitedHealth's earnings prospects. The tournament-style competition highlights contrasting strategies: traditional dividend-paying firms versus high-growth tech and fintech stocks.
IonQ (INBX) Stock Soars on Quantum Breakthrough and $2B Deal – Bubble or Next Big Thing?
Previous Story

IonQ Q3 2025 Earnings (Nov. 5): Revenue Soars 222% to $39.9M, Full‑Year Outlook Raised; Here’s What It Means for IONQ Stock

Dutch Bros (BROS) beats Q3 2025, raises full‑year sales outlook to $1.61B–$1.615B — Stock moves today (Nov. 5, 2025)
Next Story

Dutch Bros (BROS) beats Q3 2025, raises full‑year sales outlook to $1.61B–$1.615B — Stock moves today (Nov. 5, 2025)

Go toTop